Cargando…
Editorial: Novel agents and combinations for treatment of malignant pleural mesothelioma in pre-clinical models
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486835/ https://www.ncbi.nlm.nih.gov/pubmed/36147341 http://dx.doi.org/10.3389/fphar.2022.1015959 |
| _version_ | 1784792366997045248 |
|---|---|
| author | Lam, Sze-Kwan Mutsaers, Steven Eugene |
| author_facet | Lam, Sze-Kwan Mutsaers, Steven Eugene |
| author_sort | Lam, Sze-Kwan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9486835 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94868352022-09-21 Editorial: Novel agents and combinations for treatment of malignant pleural mesothelioma in pre-clinical models Lam, Sze-Kwan Mutsaers, Steven Eugene Front Pharmacol Pharmacology Frontiers Media S.A. 2022-09-06 /pmc/articles/PMC9486835/ /pubmed/36147341 http://dx.doi.org/10.3389/fphar.2022.1015959 Text en Copyright © 2022 Lam and Mutsaers. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Lam, Sze-Kwan Mutsaers, Steven Eugene Editorial: Novel agents and combinations for treatment of malignant pleural mesothelioma in pre-clinical models |
| title | Editorial: Novel agents and combinations for treatment of malignant pleural mesothelioma in pre-clinical models |
| title_full | Editorial: Novel agents and combinations for treatment of malignant pleural mesothelioma in pre-clinical models |
| title_fullStr | Editorial: Novel agents and combinations for treatment of malignant pleural mesothelioma in pre-clinical models |
| title_full_unstemmed | Editorial: Novel agents and combinations for treatment of malignant pleural mesothelioma in pre-clinical models |
| title_short | Editorial: Novel agents and combinations for treatment of malignant pleural mesothelioma in pre-clinical models |
| title_sort | editorial: novel agents and combinations for treatment of malignant pleural mesothelioma in pre-clinical models |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486835/ https://www.ncbi.nlm.nih.gov/pubmed/36147341 http://dx.doi.org/10.3389/fphar.2022.1015959 |
| work_keys_str_mv | AT lamszekwan editorialnovelagentsandcombinationsfortreatmentofmalignantpleuralmesotheliomainpreclinicalmodels AT mutsaerssteveneugene editorialnovelagentsandcombinationsfortreatmentofmalignantpleuralmesotheliomainpreclinicalmodels |